AKT1 and cardiac hypertrophy: Similarly, the overexpression of HTR2A, an upstream activator of the PI3K-AKT signaling pathway, increases the phosphorylation levels of PI3K and PDK1 in cardiomyocytes, further activating the AKT-mTOR pathway and driving cardiac hypertrophy [70].